Results 71 to 80 of about 9,741 (153)

Prasugrel [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Vascular Health and Risk Management
Mariko Kozaru, Hiroko Kambara, Akari Higuchi, Tatsuki Kagatsume, Keiko Hosohata Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, JapanCorrespondence: Keiko ...
Kozaru M, Kambara H, Higuchi A, Kagatsume T, Hosohata K   +4 more
doaj  

Ticagrelor Resistance Causing Acute In-Stent Thrombosis: Successful Management With Prasugrel and Balloon Angioplasty. [PDF]

J Med Cases
Jia K, Rimsky E, Sattarzadeh A, Pradeep AG, Amor MMI.   +4 more
europepmc   +1 more source

Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis. [PDF]

Open Heart
Zheng L, Ren Z, Shi Y, Zou J, Hao C, Li Y, Sun L, Wang D, Liu H, Liang S, Zhu B, Li C.   +11 more
europepmc   +1 more source

Retrospective observational analysis of prasugrel dosage afterpercutaneous coronary intervention using the Clinical Deep DataAccumulation System database. [PDF]

Glob Health Med
Hiroi Y, Shimizu Y, Uemura Y, Kajikawa I, Matsuo R, Yamamoto M, Hara H, Kodera S, Kiyosue A, Mizuno Y, Miyamoto Y, Nakayama M, Matoba T, Ishii M, Tsujita K, Sakata Y, Kabutoya T, Kario K, Imai Y, Makimoto H, Kohro T, Akashi N, Fujita H, Nagai R, Clidas Research Group.   +24 more
europepmc   +1 more source

Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis. [PDF]

Ther Clin Risk Manag
Li Y, Gong J, Liu N.
europepmc   +1 more source

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026. [PDF]

Cardiovasc Interv Ther
Ozaki Y, Tobe A, Onuma Y, Miyashita K, Kobayashi Y, Amano T, Yamaji K, Ishii H, Muramatsu T, Ismail TF, Kohsaka S, Nakagawa Y, Morino Y, Uemura S, Tsujita K, Shinke T, Ako J, Yajima J, Maekawa Y, Shite J, Igarashi Y, Shiode N, Okamura A, Ogawa T, Yamaguchi J, Tamura T, Tsuji T, Hayashida K, Sugano T, Okura H, Okayama H, Kawaguchi K, Zen K, Takahashi S, Nakazato K, Suematsu N, Hironaga K, Matoba T, Iida O, Ishihara M, Ohta M, Harada M, Ozaki R, Izawa H, Murohara T, Ueno T, Nakamura M, Ikari Y, Serruys PW, Kozuma K, Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT).   +50 more
europepmc   +1 more source

Evaluation of the Anti-inflammatory Effects of Ticagrelor and Prasugrel as Add-On Therapy to Aspirin in Diabetic Patients Post-percutaneous Coronary Intervention. [PDF]

Cureus
Panigrahy A, Mekala P, Pingali U, Vs B.
europepmc   +1 more source

Bridging Technique with a Stent Retriever for Iatrogenic Internal Carotid Artery Occlusion during Coil Embolization of a Ruptured Aneurysm. [PDF]

J Neuroendovasc Ther
Matsuishi M, Horio Y, Senju K, Yoshinaga S, Takemoto K, Abe H.   +5 more
europepmc   +1 more source

Adjusting Antiplatelet Therapy Using P2Y₁₂ Reaction Units in Endovascular Treatment of Unruptured Intracranial Aneurysms. [PDF]

Stroke Vasc Interv Neurol
Moon E, Song Y, Park JC, Kwon B, Park W, Ahn JS, Lee DH, Suh DC.   +7 more
europepmc   +1 more source